Cancer incidence is high worldwide, and early treatment can reduce mortality rates. Circulating tumor DNA (ctDNA) serves as a biomarker for liquid biopsy, enabling early monitoring of tumor burden and treatment response. DNA nanobiosensors have become an impor... ...

请注册登录后继续浏览